Ranbaxy Laboratories signs agreement with Medy-Tox for Neuronox

Posted on: Thu, 17 Sep 2009 15:08:00 EDT


Symbols: RBXLF
Sep 17, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
RBXLF | Quote | Chart | News | PowerRating -- Ranbaxy Laboratories Limited, an India-based research-based pharmaceutical company, has entered into an in-licensing agreement with Medy-Tox, Inc., a Korea-based biotechnology company, for Neuronox, a cosmetic product.

Deal Type    Partnership
Sub-Category Licensing Agreement
Deal Status Announced: 2009-09-17

Deal Participants

Partner 1 (Company) Medy-Tox, Inc.
Partner 2 (Company) Ranbaxy Laboratories Limited

Deal Rationale

The licensing agreement would enable Ranbaxy Laboratories to strengthen its presence in the dermatological segment.

For full details on (RBXLF) RBXLF. (RBXLF) has Short Term PowerRatings at TradingMarkets. Details on (RBXLF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.